European Leukemia Trial Registry
Trial: CML 2004 IMATINIB #068

More Details
Title Treatment of CML-patients with Imatinib and Hydroxyurea
Scientific Title TREATMENT OF CML PATIENTS WITH IMATINIB + HYDROXYUREA
Short Title CML 2004 IMATINIB #068
Trialgroup OSHO
Disease Chronic myeloid leukemia(CML) Chronic Phase
Age >= 18 years
Status Closed
Start of Recruitment 27.04.2004
Leader Niederwieser, Prof. Dr. med. Dr. h.c., Dietger
Contactperson

principal investigator
Lange, PD Dr. med., Thoralf

Study Centre
Otto, Sandra
Tel: +49 (0)341 97-13132
Fax: +49 (0)341 97-13139
Email: sandra.otto@medizin.uni-leipzig.de
Homepage: http://haemonko.uniklinikum-leipzig.de

Centre of Trial Universitätsklinikum Leipzig
Shortprotocol Shortprotocol
created 11.05.2007 Anja Hellenbrecht
changed 04.01.2017 Eva-Maria Ableidinger
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org